reviewCirculationMay 22, 2019GREEN OA

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

PUPhilip UrbanRMRoxana MehranRCRóisín ColleranDJDominick J. AngiolilloRARobert A. Byrne

Cardiovascular European Research Center · Hôpital de la Tour · +39 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Identification and management of patients at high bleeding risk undergoing percutaneous coronary intervention are of major importance, but a lack of standardization in defining this population limits trial design, data interpretation, and clinical decision-making. The Academic Research Consortium for High Bleeding Risk (ARC-HBR) is a collaboration among leading research organizations, regulatory authorities, and physician-scientists from the United States, Asia, and Europe focusing on percutaneous coronary intervention-related bleeding. Two meetings of the 31-member consortium were held in Washington, DC, in April 2018 and in Paris, France, in October 2018. These meetings were organized by the Cardiovascular…

Citation impact

783
total citations
FWCI
65.89
Percentile
100%
References
146
Citations per year

Authors

34

Topics & keywords

Topics
Keywords
  • Medicine
  • Percutaneous coronary intervention
  • Clinical trial
  • Population
  • Guideline
  • Regulatory affairs
  • Intensive care medicine
  • Medical emergency
No related works found for this paper.

Funding